1.Cephalometric assessment after surgical correction of V.P.I.
Pyung Bae CHAE ; Myung Rae KIM
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1993;19(3):337-346
No abstract available.
2.A Study of Plasma Apolipoprotein A-1 and Apolipoprotein B Levels in Patients with Coronary Artery Disease.
Yeul BAE ; Jae Young RHEW ; In Jong CHO ; Moon Hee RYU ; Jung Pyung SEO ; Gwang Chae GILL ; Joo Hyung PARK ; Myung Ho JEONG ; Jeong Gwan CHO ; Jong Chun PARK ; Jung Chaee KANG
Korean Circulation Journal 1995;25(5):967-974
BACKGROUND: It is known that dyslipidemia plays and important role in atherogenesis and progression for the disease. Recently it was reported that apolipoprotein levels are important in athcrogenesis. In Korean patients the study of the apolipoprotein levels as for the risk factor for atherogenesis is still needed. Subjects and METHODS: The 107 patients who underwent coronary angiography to differentiate chest pain syndrome were subjected to this study. Thirty-two patients who had no significant coronary artery disease served as a control group and 75 patients who had one or more coronary stenoses more than 50% narrowing by luminal diameter served as the coronary artery disease(CAD) group. Plasma levels of total cholesterol, triglycerides, high density lipoprotein cholestero(HDL-C), apolipoprotein A-1(Apo- A1) and apolipoprotein B(Apo B) were measured from venous blood after overnight fastion, and the results were compared between the groups. RESULTS: The male gender and smoking habits were more prevalent in the CAD group. Total cholesterol levels were significantly higher in the CAD group but the HDL-C level was not significantly different in two groups though the mean level of the HDL-C was some lower in the CAD group. The Apo A-1 level was lowere in the CAD group while the Apo B level was higher in teh CAD group compared to those of the control, Apo B / Apo A-1 ratio much more distinctly discriminated the two groups. CONCLUSION: Theses results suggest that the plasma Apo-A-1, Apo B levels and the ratio of Apo B / Apo A-1 can be used for risk statification of CAD.
Apolipoprotein A-I*
;
Apolipoproteins B
;
Apolipoproteins*
;
Atherosclerosis
;
Chest Pain
;
Cholesterol
;
Coronary Angiography
;
Coronary Artery Disease*
;
Coronary Stenosis
;
Coronary Vessels*
;
Dyslipidemias
;
Humans
;
Lipoproteins
;
Male
;
Phenobarbital
;
Plasma*
;
Risk Factors
;
Smoke
;
Smoking
;
Triglycerides